Prescribing off-label COVID boosters may put providers at legal risk: report
By
Alicia Lasek
Sep 06, 2021
Clinicians who provide additional COVID-19 shots to fully vaccinated patients may be at risk for legal claims if they prescribe the doses outside of current federal guidelines, CDC says.
Moderna vaccine may shield more against breakthrough infections than Pfizer: study
Aug 12, 2021
Findings based on non-peer-reviewed, preprint data
U.S. gives green light to Moderna’s COVID-19 vaccine
By
Alicia Lasek
Feb 01, 2022
“Spikevax” is the second COVID-19 mRNA vaccine to receive full FDA approval, following Pfizer-BioNTech’s Comirnaty in September.
mRNA-1273 has high vaccine effectiveness after five months
Dec 03, 2021
Vaccine effectiveness 87.4 percent against COVID-19 infection, and 95.8 and 97.9 percent against COVID-19 hospitalization, hospital death
FDA expands COVID booster shot access; says vaccines can be mixed or matched
By
Alicia Lasek
Oct 21, 2021
The agency has amended the emergency use authorizations for Moderna’s and Johnson & Johnson’s COVID-19 vaccines to allow for the use of a single booster dose in certain eligible groups.